| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Array Analysis | 4 | 2021 | 101 | 1.270 |
Why?
|
| Mammary Neoplasms, Animal | 6 | 2018 | 139 | 1.060 |
Why?
|
| Breast Neoplasms | 17 | 2021 | 2513 | 0.900 |
Why?
|
| Proteomics | 5 | 2021 | 500 | 0.790 |
Why?
|
| Wnt1 Protein | 7 | 2018 | 71 | 0.690 |
Why?
|
| Gene Expression Profiling | 8 | 2016 | 1699 | 0.630 |
Why?
|
| Receptor, ErbB-2 | 8 | 2019 | 514 | 0.580 |
Why?
|
| Mammary Tumor Virus, Mouse | 5 | 2018 | 106 | 0.550 |
Why?
|
| Mammary Glands, Animal | 7 | 2018 | 482 | 0.550 |
Why?
|
| Signal Transduction | 17 | 2021 | 4543 | 0.530 |
Why?
|
| Gene Expression Regulation, Neoplastic | 12 | 2020 | 1899 | 0.490 |
Why?
|
| Mice | 46 | 2021 | 17757 | 0.480 |
Why?
|
| Proteins | 2 | 2021 | 1046 | 0.450 |
Why?
|
| Proteasome Endopeptidase Complex | 4 | 2016 | 266 | 0.410 |
Why?
|
| Cell Line, Tumor | 17 | 2021 | 3342 | 0.370 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2020 | 237 | 0.370 |
Why?
|
| Animals | 47 | 2021 | 34200 | 0.370 |
Why?
|
| Biomarkers, Tumor | 4 | 2020 | 1473 | 0.360 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 670 | 0.360 |
Why?
|
| Autoantigens | 4 | 2016 | 119 | 0.360 |
Why?
|
| Pancreatic Neoplasms | 4 | 2020 | 687 | 0.320 |
Why?
|
| Trans-Activators | 4 | 2003 | 809 | 0.320 |
Why?
|
| ErbB Receptors | 3 | 2021 | 284 | 0.320 |
Why?
|
| Neuroendocrine Tumors | 2 | 2020 | 53 | 0.310 |
Why?
|
| Pyridines | 2 | 2020 | 230 | 0.300 |
Why?
|
| Drug Resistance, Neoplasm | 7 | 2019 | 721 | 0.300 |
Why?
|
| Wnt Proteins | 4 | 2021 | 195 | 0.300 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2018 | 618 | 0.290 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2020 | 219 | 0.280 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 2 | 2020 | 88 | 0.280 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1999 | 118 | 0.270 |
Why?
|
| Receptors, Estrogen | 4 | 2021 | 796 | 0.270 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2021 | 356 | 0.260 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2020 | 235 | 0.260 |
Why?
|
| Smad1 Protein | 4 | 2011 | 22 | 0.260 |
Why?
|
| Bone Neoplasms | 3 | 2021 | 430 | 0.260 |
Why?
|
| Genes, Dominant | 1 | 2006 | 247 | 0.260 |
Why?
|
| DNA-Binding Proteins | 4 | 2018 | 2060 | 0.250 |
Why?
|
| Cell Proliferation | 9 | 2020 | 2307 | 0.250 |
Why?
|
| Mice, Transgenic | 11 | 2013 | 2411 | 0.240 |
Why?
|
| Indoles | 2 | 2017 | 181 | 0.240 |
Why?
|
| Lung Neoplasms | 3 | 2018 | 1605 | 0.240 |
Why?
|
| Pyrroles | 2 | 2017 | 179 | 0.240 |
Why?
|
| Female | 38 | 2021 | 66575 | 0.230 |
Why?
|
| Estrogen Receptor alpha | 3 | 2016 | 468 | 0.220 |
Why?
|
| Disease Models, Animal | 9 | 2021 | 4359 | 0.210 |
Why?
|
| Phenylurea Compounds | 2 | 2020 | 48 | 0.200 |
Why?
|
| Calcium | 2 | 1999 | 1099 | 0.200 |
Why?
|
| Kidney Neoplasms | 2 | 2017 | 431 | 0.190 |
Why?
|
| Fibroblasts | 4 | 2021 | 891 | 0.190 |
Why?
|
| Cytokines | 3 | 2017 | 1290 | 0.190 |
Why?
|
| MicroRNAs | 2 | 2020 | 842 | 0.190 |
Why?
|
| Neoplasm Metastasis | 2 | 2021 | 670 | 0.190 |
Why?
|
| MAP Kinase Signaling System | 2 | 2021 | 316 | 0.190 |
Why?
|
| Neuroblastoma | 2 | 2020 | 519 | 0.190 |
Why?
|
| Retinoids | 1 | 2021 | 33 | 0.180 |
Why?
|
| Protein Kinase C | 2 | 2018 | 150 | 0.180 |
Why?
|
| Mice, Knockout | 6 | 2016 | 3754 | 0.180 |
Why?
|
| Transcriptome | 2 | 2018 | 939 | 0.180 |
Why?
|
| Stem Cells | 3 | 2018 | 702 | 0.180 |
Why?
|
| Friedreich Ataxia | 1 | 2021 | 48 | 0.180 |
Why?
|
| Antineoplastic Agents | 3 | 2019 | 1668 | 0.180 |
Why?
|
| Quality Control | 1 | 2021 | 119 | 0.180 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2021 | 39 | 0.180 |
Why?
|
| Intestinal Neoplasms | 1 | 2021 | 39 | 0.180 |
Why?
|
| Tamoxifen | 4 | 2016 | 363 | 0.180 |
Why?
|
| Enterocytes | 1 | 2021 | 75 | 0.170 |
Why?
|
| Insulins | 1 | 2020 | 17 | 0.170 |
Why?
|
| Ileum | 1 | 2021 | 132 | 0.170 |
Why?
|
| Isotretinoin | 1 | 2020 | 26 | 0.170 |
Why?
|
| Proteome | 2 | 2021 | 243 | 0.170 |
Why?
|
| Biomarkers | 4 | 2021 | 3064 | 0.170 |
Why?
|
| Cell Division | 3 | 2013 | 782 | 0.170 |
Why?
|
| Humans | 42 | 2021 | 124802 | 0.170 |
Why?
|
| Anilides | 1 | 2020 | 48 | 0.170 |
Why?
|
| Prodrugs | 1 | 2020 | 59 | 0.170 |
Why?
|
| Mevalonic Acid | 1 | 2019 | 19 | 0.170 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 550 | 0.160 |
Why?
|
| Adaptation, Physiological | 1 | 2021 | 272 | 0.160 |
Why?
|
| Interleukin-2 | 1 | 2020 | 226 | 0.160 |
Why?
|
| Androgen Antagonists | 1 | 2020 | 119 | 0.160 |
Why?
|
| Cell Cycle | 5 | 2020 | 615 | 0.160 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2020 | 152 | 0.160 |
Why?
|
| Bone and Bones | 1 | 2021 | 267 | 0.160 |
Why?
|
| Receptors, CCR2 | 1 | 2018 | 24 | 0.160 |
Why?
|
| Mammary Neoplasms, Experimental | 3 | 2015 | 247 | 0.160 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2019 | 58 | 0.150 |
Why?
|
| Metformin | 1 | 2020 | 150 | 0.150 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 292 | 0.150 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2016 | 1019 | 0.150 |
Why?
|
| Myotonin-Protein Kinase | 1 | 2018 | 44 | 0.150 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2020 | 888 | 0.150 |
Why?
|
| Polyethylene Glycols | 1 | 2020 | 223 | 0.150 |
Why?
|
| Receptor, trkA | 1 | 2018 | 16 | 0.150 |
Why?
|
| TNF Receptor-Associated Factor 4 | 1 | 2018 | 18 | 0.150 |
Why?
|
| Phosphorylation | 6 | 2019 | 1626 | 0.150 |
Why?
|
| src-Family Kinases | 1 | 2018 | 90 | 0.150 |
Why?
|
| NIMA-Related Kinases | 1 | 2018 | 13 | 0.150 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2018 | 37 | 0.150 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2017 | 153 | 0.150 |
Why?
|
| Ubiquitin | 2 | 2021 | 142 | 0.150 |
Why?
|
| Pulmonary Alveoli | 1 | 2018 | 134 | 0.150 |
Why?
|
| Carcinogenesis | 3 | 2020 | 333 | 0.140 |
Why?
|
| Morpholines | 1 | 2018 | 57 | 0.140 |
Why?
|
| Neoplasm Transplantation | 4 | 2021 | 375 | 0.140 |
Why?
|
| Muscle Weakness | 1 | 2018 | 84 | 0.140 |
Why?
|
| MutL Proteins | 1 | 2017 | 19 | 0.140 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2020 | 428 | 0.140 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2018 | 73 | 0.140 |
Why?
|
| Aminopyridines | 1 | 2018 | 55 | 0.140 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2017 | 36 | 0.140 |
Why?
|
| Stromal Cells | 2 | 2016 | 299 | 0.140 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2017 | 21 | 0.140 |
Why?
|
| Wnt Signaling Pathway | 2 | 2021 | 196 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2017 | 41 | 0.140 |
Why?
|
| Hyperthermia, Induced | 1 | 2017 | 47 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2017 | 57 | 0.140 |
Why?
|
| Everolimus | 1 | 2017 | 47 | 0.140 |
Why?
|
| GTPase-Activating Proteins | 1 | 2017 | 85 | 0.140 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 294 | 0.140 |
Why?
|
| Batch Cell Culture Techniques | 1 | 2016 | 6 | 0.140 |
Why?
|
| Myotonic Dystrophy | 1 | 2018 | 148 | 0.130 |
Why?
|
| Neoplastic Stem Cells | 2 | 2017 | 300 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 555 | 0.130 |
Why?
|
| Up-Regulation | 2 | 2018 | 867 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2016 | 49 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 538 | 0.130 |
Why?
|
| Hexosamines | 1 | 2016 | 16 | 0.130 |
Why?
|
| Spheroids, Cellular | 1 | 2016 | 58 | 0.130 |
Why?
|
| Cardiomyopathies | 1 | 2021 | 489 | 0.130 |
Why?
|
| Sarcoma, Ewing | 1 | 2017 | 116 | 0.130 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 242 | 0.130 |
Why?
|
| I-kappa B Kinase | 1 | 2016 | 61 | 0.130 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 530 | 0.130 |
Why?
|
| Tissue Scaffolds | 1 | 2016 | 73 | 0.130 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2016 | 47 | 0.130 |
Why?
|
| Hypothalamus | 1 | 2017 | 221 | 0.130 |
Why?
|
| Printing, Three-Dimensional | 1 | 2016 | 67 | 0.130 |
Why?
|
| Precancerous Conditions | 1 | 2018 | 283 | 0.120 |
Why?
|
| Apoptosis | 6 | 2019 | 1792 | 0.120 |
Why?
|
| Interleukin-8 | 1 | 2016 | 209 | 0.120 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2018 | 190 | 0.120 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2015 | 66 | 0.120 |
Why?
|
| RNA, Small Interfering | 4 | 2018 | 670 | 0.120 |
Why?
|
| Epidermal Growth Factor | 1 | 1995 | 122 | 0.120 |
Why?
|
| Enzyme Activation | 4 | 2018 | 626 | 0.120 |
Why?
|
| Protein Kinases | 1 | 2016 | 334 | 0.120 |
Why?
|
| Tissue Engineering | 1 | 2016 | 174 | 0.120 |
Why?
|
| Cell Movement | 4 | 2021 | 835 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 7 | 2020 | 4431 | 0.110 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase Catalytic Subunits | 1 | 2014 | 3 | 0.110 |
Why?
|
| Colitis | 1 | 2016 | 154 | 0.110 |
Why?
|
| Heterografts | 3 | 2019 | 178 | 0.110 |
Why?
|
| Guidelines as Topic | 1 | 2015 | 197 | 0.110 |
Why?
|
| STAT5 Transcription Factor | 2 | 2013 | 90 | 0.110 |
Why?
|
| Antineoplastic Agents, Hormonal | 3 | 2016 | 256 | 0.110 |
Why?
|
| MCF-7 Cells | 3 | 2021 | 222 | 0.110 |
Why?
|
| Synapses | 1 | 2017 | 457 | 0.110 |
Why?
|
| Mice, Nude | 4 | 2021 | 711 | 0.110 |
Why?
|
| Casein Kinase Idelta | 1 | 2013 | 5 | 0.110 |
Why?
|
| NF-kappa B | 1 | 2016 | 457 | 0.110 |
Why?
|
| Hypertension, Pulmonary | 1 | 2018 | 435 | 0.110 |
Why?
|
| Receptors, Progesterone | 1 | 2017 | 879 | 0.110 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2013 | 61 | 0.110 |
Why?
|
| Aging, Premature | 1 | 2013 | 30 | 0.110 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2015 | 208 | 0.110 |
Why?
|
| Melanoma | 1 | 2020 | 835 | 0.100 |
Why?
|
| Drug Synergism | 3 | 2020 | 230 | 0.100 |
Why?
|
| DNA Damage | 1 | 2015 | 516 | 0.100 |
Why?
|
| Cell Line | 5 | 2016 | 2771 | 0.100 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2011 | 11 | 0.100 |
Why?
|
| Male | 16 | 2021 | 61302 | 0.100 |
Why?
|
| DNA Repair | 1 | 2015 | 587 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2020 | 488 | 0.100 |
Why?
|
| Mice, SCID | 3 | 2018 | 571 | 0.100 |
Why?
|
| Transcription, Genetic | 4 | 2017 | 1704 | 0.100 |
Why?
|
| Cell Survival | 3 | 2020 | 807 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 410 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2014 | 366 | 0.090 |
Why?
|
| Keratin-6 | 1 | 2011 | 13 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 1113 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 130 | 0.090 |
Why?
|
| Smad Proteins | 2 | 2002 | 44 | 0.090 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2020 | 215 | 0.090 |
Why?
|
| Bone Development | 1 | 2011 | 57 | 0.090 |
Why?
|
| Genes, erbB-2 | 1 | 2010 | 37 | 0.090 |
Why?
|
| Estrogens | 2 | 2010 | 515 | 0.090 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2010 | 47 | 0.090 |
Why?
|
| Polyomavirus | 1 | 2010 | 32 | 0.090 |
Why?
|
| Lung | 1 | 2018 | 1492 | 0.090 |
Why?
|
| Neoplasms, Experimental | 1 | 2011 | 214 | 0.090 |
Why?
|
| Protein Binding | 4 | 2019 | 1749 | 0.090 |
Why?
|
| Prognosis | 5 | 2020 | 4615 | 0.090 |
Why?
|
| Autophagy | 1 | 2013 | 395 | 0.090 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2010 | 83 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 1135 | 0.080 |
Why?
|
| Prostatic Neoplasms | 1 | 2018 | 1549 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2021 | 3061 | 0.080 |
Why?
|
| Skin | 3 | 2013 | 512 | 0.080 |
Why?
|
| Disease Progression | 3 | 2021 | 2052 | 0.080 |
Why?
|
| Cornea | 1 | 2014 | 653 | 0.080 |
Why?
|
| Smad8 Protein | 1 | 2008 | 6 | 0.080 |
Why?
|
| Ubiquitination | 2 | 2019 | 174 | 0.070 |
Why?
|
| Smad5 Protein | 1 | 2008 | 22 | 0.070 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2008 | 31 | 0.070 |
Why?
|
| Activin Receptors, Type I | 1 | 2008 | 34 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 354 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 2 | 2021 | 612 | 0.070 |
Why?
|
| Mullerian Ducts | 1 | 2008 | 33 | 0.070 |
Why?
|
| Ovary | 1 | 2010 | 380 | 0.070 |
Why?
|
| Mice, Inbred NOD | 2 | 2018 | 285 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 1319 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 1001 | 0.070 |
Why?
|
| Avian Sarcoma Viruses | 1 | 2006 | 32 | 0.070 |
Why?
|
| Ovariectomy | 3 | 2017 | 183 | 0.070 |
Why?
|
| Hypertension | 1 | 2015 | 1316 | 0.070 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2008 | 339 | 0.070 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2006 | 88 | 0.070 |
Why?
|
| Estradiol | 3 | 2017 | 535 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2020 | 339 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2021 | 753 | 0.070 |
Why?
|
| Drug Therapy, Combination | 2 | 2020 | 1162 | 0.060 |
Why?
|
| Immunohistochemistry | 3 | 2011 | 1691 | 0.060 |
Why?
|
| Quinazolines | 3 | 2015 | 176 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2006 | 198 | 0.060 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2020 | 93 | 0.060 |
Why?
|
| Genes, Neoplasm | 1 | 2005 | 80 | 0.060 |
Why?
|
| Hyperplasia | 1 | 2005 | 208 | 0.060 |
Why?
|
| Base Sequence | 2 | 2018 | 3100 | 0.060 |
Why?
|
| Animals, Newborn | 2 | 2018 | 1010 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 282 | 0.050 |
Why?
|
| Embryo, Mammalian | 2 | 2017 | 456 | 0.050 |
Why?
|
| COS Cells | 2 | 2000 | 276 | 0.050 |
Why?
|
| Immunoblotting | 2 | 2011 | 313 | 0.050 |
Why?
|
| Zebrafish Proteins | 1 | 2003 | 111 | 0.050 |
Why?
|
| Neoplasms | 1 | 2017 | 2789 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2006 | 940 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2021 | 1929 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2018 | 2825 | 0.050 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2021 | 19 | 0.050 |
Why?
|
| Neoplasm Micrometastasis | 1 | 2021 | 12 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2019 | 467 | 0.050 |
Why?
|
| Iron-Binding Proteins | 1 | 2021 | 32 | 0.050 |
Why?
|
| Gap Junctions | 1 | 2021 | 38 | 0.050 |
Why?
|
| Tissue Array Analysis | 1 | 2021 | 137 | 0.050 |
Why?
|
| Clonal Evolution | 1 | 2021 | 41 | 0.050 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2021 | 65 | 0.050 |
Why?
|
| Neoplasm Staging | 2 | 2017 | 1228 | 0.040 |
Why?
|
| 5' Untranslated Regions | 1 | 2000 | 59 | 0.040 |
Why?
|
| Cell Communication | 1 | 2021 | 167 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2020 | 42 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 551 | 0.040 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2020 | 43 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2020 | 62 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2000 | 388 | 0.040 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2020 | 17 | 0.040 |
Why?
|
| Osteogenesis | 1 | 2021 | 155 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2021 | 383 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2000 | 464 | 0.040 |
Why?
|
| Ipilimumab | 1 | 2020 | 45 | 0.040 |
Why?
|
| Introns | 1 | 2000 | 301 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2021 | 393 | 0.040 |
Why?
|
| Genes | 1 | 2000 | 445 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2021 | 973 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2000 | 658 | 0.040 |
Why?
|
| Survival Rate | 2 | 2020 | 2035 | 0.040 |
Why?
|
| Genotype | 1 | 2005 | 2557 | 0.040 |
Why?
|
| Longevity | 1 | 2021 | 140 | 0.040 |
Why?
|
| Lanthanum | 1 | 1999 | 4 | 0.040 |
Why?
|
| Intracellular Fluid | 1 | 1999 | 24 | 0.040 |
Why?
|
| Thapsigargin | 1 | 1999 | 22 | 0.040 |
Why?
|
| ras Proteins | 1 | 2020 | 137 | 0.040 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1999 | 23 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1999 | 18 | 0.040 |
Why?
|
| Type C Phospholipases | 1 | 1999 | 28 | 0.040 |
Why?
|
| Nifedipine | 1 | 1999 | 21 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2000 | 2705 | 0.040 |
Why?
|
| Pertussis Toxin | 1 | 1999 | 28 | 0.040 |
Why?
|
| Phospholipase C gamma | 1 | 1999 | 19 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2017 | 12341 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2019 | 137 | 0.040 |
Why?
|
| Verapamil | 1 | 1999 | 55 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2020 | 207 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2000 | 627 | 0.040 |
Why?
|
| Middle Aged | 4 | 2021 | 26727 | 0.040 |
Why?
|
| Extracellular Space | 1 | 1999 | 88 | 0.040 |
Why?
|
| Genes, p53 | 2 | 2013 | 212 | 0.040 |
Why?
|
| Trastuzumab | 1 | 2019 | 134 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 1999 | 115 | 0.040 |
Why?
|
| Cell Growth Processes | 1 | 2018 | 63 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2021 | 701 | 0.040 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2019 | 166 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2000 | 3882 | 0.040 |
Why?
|
| Protein Transport | 1 | 2019 | 369 | 0.040 |
Why?
|
| Isoenzymes | 1 | 1999 | 229 | 0.040 |
Why?
|
| CELF1 Protein | 1 | 2018 | 48 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 1028 | 0.040 |
Why?
|
| Chemokine CCL2 | 1 | 2018 | 121 | 0.040 |
Why?
|
| Calmodulin | 1 | 1999 | 230 | 0.040 |
Why?
|
| Transfection | 2 | 2010 | 1069 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 6522 | 0.040 |
Why?
|
| Phenotype | 2 | 2019 | 4260 | 0.040 |
Why?
|
| Exons | 1 | 2000 | 796 | 0.040 |
Why?
|
| Pancreatic Stellate Cells | 1 | 2017 | 7 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2000 | 486 | 0.040 |
Why?
|
| Aged | 3 | 2021 | 19693 | 0.040 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2018 | 124 | 0.040 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2017 | 31 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2020 | 503 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2020 | 693 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2021 | 795 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2017 | 70 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 395 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 2017 | 106 | 0.030 |
Why?
|
| p21-Activated Kinases | 1 | 2017 | 58 | 0.030 |
Why?
|
| Sulfonamides | 1 | 1999 | 264 | 0.030 |
Why?
|
| Aromatase Inhibitors | 1 | 2017 | 77 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2020 | 682 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 2017 | 153 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 2539 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 331 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2017 | 412 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2017 | 400 | 0.030 |
Why?
|
| Dextran Sulfate | 1 | 2016 | 48 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2016 | 56 | 0.030 |
Why?
|
| RNA Interference | 1 | 2018 | 504 | 0.030 |
Why?
|
| Ligands | 1 | 2017 | 536 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 1999 | 582 | 0.030 |
Why?
|
| Mutation | 3 | 2019 | 5814 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 1341 | 0.030 |
Why?
|
| Gene Amplification | 1 | 2016 | 228 | 0.030 |
Why?
|
| Tenascin | 1 | 2015 | 31 | 0.030 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1995 | 69 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2016 | 238 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2016 | 96 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 504 | 0.030 |
Why?
|
| Myelin Basic Protein | 1 | 1995 | 69 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 1068 | 0.030 |
Why?
|
| Models, Biological | 2 | 2013 | 1461 | 0.030 |
Why?
|
| Drug Design | 1 | 2016 | 146 | 0.030 |
Why?
|
| DNA | 1 | 2000 | 1604 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 1570 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 1691 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2000 | 1760 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 178 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 457 | 0.030 |
Why?
|
| Collagen | 1 | 2015 | 316 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 577 | 0.030 |
Why?
|
| E-Selectin | 1 | 2014 | 41 | 0.030 |
Why?
|
| Epithelial Cells | 2 | 2010 | 910 | 0.030 |
Why?
|
| Swine | 1 | 2017 | 1173 | 0.030 |
Why?
|
| Adult | 3 | 2021 | 29482 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2017 | 527 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2014 | 63 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 101 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1248 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2014 | 94 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2014 | 85 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2013 | 91 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2000 | 1272 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 1995 | 405 | 0.030 |
Why?
|
| Kinetics | 1 | 1995 | 1325 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2013 | 46 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 2016 | 249 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 868 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2019 | 1004 | 0.030 |
Why?
|
| Retroviridae | 1 | 2013 | 198 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 3690 | 0.030 |
Why?
|
| Oncogenes | 1 | 2013 | 169 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 1008 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 170 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2013 | 79 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 1498 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 208 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2015 | 372 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2015 | 367 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 953 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2011 | 60 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2013 | 184 | 0.020 |
Why?
|
| Diet, High-Fat | 1 | 2013 | 214 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2011 | 124 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2013 | 809 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2011 | 60 | 0.020 |
Why?
|
| Avian Leukosis Virus | 1 | 2011 | 14 | 0.020 |
Why?
|
| Trabecular Meshwork | 1 | 2011 | 11 | 0.020 |
Why?
|
| Inflammation | 1 | 2018 | 1430 | 0.020 |
Why?
|
| Collagen Type II | 1 | 2011 | 24 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2011 | 98 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2016 | 779 | 0.020 |
Why?
|
| X-Ray Microtomography | 1 | 2011 | 83 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2013 | 359 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 4786 | 0.020 |
Why?
|
| Aorta | 1 | 2014 | 537 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 3143 | 0.020 |
Why?
|
| Chickens | 1 | 2010 | 638 | 0.020 |
Why?
|
| Genome, Human | 1 | 2016 | 1273 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 510 | 0.020 |
Why?
|
| Algorithms | 1 | 2016 | 1616 | 0.020 |
Why?
|
| Progesterone | 1 | 2011 | 625 | 0.020 |
Why?
|
| Adolescent | 2 | 2021 | 19330 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 724 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 1110 | 0.020 |
Why?
|
| Pregnancy | 2 | 2013 | 7172 | 0.020 |
Why?
|
| Recurrence | 1 | 2011 | 1426 | 0.020 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2008 | 37 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 1328 | 0.020 |
Why?
|
| Neurons | 1 | 2017 | 1964 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 384 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 8991 | 0.020 |
Why?
|
| Oncogenic Viruses | 1 | 2006 | 17 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2006 | 112 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 2043 | 0.020 |
Why?
|
| Mitogens | 1 | 2005 | 31 | 0.020 |
Why?
|
| Infertility, Male | 1 | 2008 | 263 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2005 | 101 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 1351 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2005 | 212 | 0.010 |
Why?
|
| Genes, myc | 1 | 2003 | 100 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2005 | 260 | 0.010 |
Why?
|
| beta Catenin | 1 | 2003 | 206 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1995 | 8182 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2003 | 269 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 1237 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2000 | 152 | 0.010 |
Why?
|
| Smad2 Protein | 1 | 2000 | 49 | 0.010 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2000 | 52 | 0.010 |
Why?
|
| Smad4 Protein | 1 | 2000 | 55 | 0.010 |
Why?
|
| Proline | 1 | 2000 | 78 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2000 | 459 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2000 | 291 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 6311 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 757 | 0.010 |
Why?
|
| Risk Factors | 1 | 2011 | 10272 | 0.010 |
Why?
|
| Infant | 1 | 2011 | 12481 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2011 | 14050 | 0.010 |
Why?
|
| Child | 1 | 2011 | 24456 | 0.010 |
Why?
|